Loading...

We are the Peptide Experts


JPT Peptide Technologies is the leading manufacturer of custom peptides and innovative peptide-based products for research and clinical applications. For more than 15 years we have been serving the worldwide biomedical community with science and quality driven products and services.

Located in our state-of-the-art laboratories in Berlin, Germany, JPT operates according to the most recent ISO 9001:2015 regulations.


Custom Peptide Synthesis


Product Finder

Search by scientific field

Research Fields

Cell Therapy & Vaccines

Cell Therapy & Vaccines

JPT offers a large portfolio of peptide products and services supporting all development phases of new cell therapies and vaccines. These products range from discovery tools for epitope and target identification, to various peptide formats for immune monitoring and clinical grade peptides to support clinical vaccination and cell therapy trials.  Learn more
Immunology

Immunology

JPT has developed a variety of unique peptide-based products allowing systematic evaluation of cellular and humoral immunity. In addition to peptide formats allowing T-cell and B-cell epitope discovery, antigen-specific T-cell stimulation and immune monitoring our clinical grade products support clinical trials for the development of new immunotherapeutics and vaccines. Learn more
Neo-Epitope Discovery & Therapy

Neo-Epitope Discovery & Therapy

Neo-epitopes are important targets for individualized cancer immunotherapy. JPT’s high-throughput peptide techniques enable access to customized peptide products for neo-epitope prioritization and validation, individualized therapy development and immune monitoring. Learn more
Proteomics

Proteomics

Proteomics is the study of a cell's protein inventory at different times by protein identification and quantification. The application of mass spectrometry and more specifically LC-MS/MS has tremendously facilitated this process. JPT developed proprietary approaches for the provision of quantified custom peptides and ready-to-use products enabling protein biomarker identification and quantitation. Learn more
COVID-19

COVID-19

JPT was the first company responding to the Covid-19 pandemic with the launch of a broad SARS CoV-2 genome spanning portfolio of peptide tools. The ready to use and custom peptide tools include antigen spanning PepMixTM peptide pools and PepStarTM peptide microarrays of SARS-CoV-2 wild type and mutated antigen sequences as well as antigens from other relevant corona viruses.  Learn more
Loading...

News

NEW: PepMix™ & PepStar™ for Adenovirus Proteins
We are proud to announce the launch of our new PepMix™ peptide pools & PepStar™ peptide microarryas for both capsid proteins, Penton and Hexon, in either Chimpanzee AdV-vector Y25 or Human AdV-vector 26:
PepMix™ Chimpanzee AdV Y25 (Penton Protein)
PepMix™ Human AdV 26 (Penton Protein)

January 2022
NEW: Omicron & Lambda Peptide Pools & Microarrays
Today we announce the launch of additional PepMix™ peptide pools and our corresponding updated PepStar™ peptide microarrays.
PepMix™ SARS-CoV-2 Omicron, B.1.1.259: Spike, Spike-RBD, NCAP, VEMP, VME1
PepMix™ Sars-Cov-2 Lambda, C.37: Spike, Spike-RBD
PepStar™ SARS-COV-2 (Spike) Wild type + Omicron

January 2022
Happy New Year!
Since more than 17 years, it has been our pleasure to provide you with our high quality peptides and peptide tools, and we want to express our deep gratitude for your trust and loyalty! We would not have been able to go through this crisis without your input: the continuous interaction with you, your comments, questions, recommendations and critiques supported us to keep innovating and improve. Find last year's highlights!

January 2022

Check our list of products, click and go.

Get a quote